News

Sera Prognostics’ PreTrm Biomarker Test Predicts Adverse Pregnancy Outcomes

New data from the multicenter assessment of a spontaneous preterm birth risk predictor (Treetop), a large, prospective US study, has demonstrated that Read more...

Catalyst Health Ventures – Investment Associate Position

Investment Associate: Position Description Catalyst is a Healthcare focused venture capital fund with a long track record of successfully investing Read more...

Atacor raises $25M to make regulatory case for temporary extracardiac cardiac pacing

By Stacy Lawrence Temporary cardiac pacing is often required for hospitalized cardiac patients, particularly for increasingly common transcatheter Read more...

AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, Read more...

Sera Prognostics appoints Jay M. Moyes as Chief Financial Officer

April 2, 2020 –Salt Lake City Utah –Sera Prognostics, Inc., The Pregnancy Company™, focused on improving maternal and neonatal health through innovative Read more...

Aria completes $31m Series B for its pulmonary hypertension treatment device

Pulmonary arterial hypertension (PAH) treatment developer Aria CV announced today that it completed a $31 million Series B financing round. The proceeds Read more...

SERA PROGNOSTICS TO PRESENT AT THE 40TH ANNUAL COWEN HEALTH CARE CONFERENCE

February 24, 2020 — Sera Prognostics, Inc., the leading health diagnostics company dedicated to improving the lives of women and babies through individualized Read more...

Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension

SAINT PAUL, Minn.--(BUSINESS WIRE)--Aria CV, Inc., a developer of medical devices treating Pulmonary Arterial Hypertension (PAH), today announced that Read more...

Page 2 of 33123...Last »

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184